{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:25:10Z","timestamp":1791876310330,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T00:00:00Z","timestamp":1394582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"},{"start":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T00:00:00Z","timestamp":1394582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep04362","type":"journal-article","created":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T10:10:05Z","timestamp":1394619005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Soybean greatly reduces valproic acid plasma concentrations: A food\u2013drug interaction study"],"prefix":"10.1038","volume":"4","author":[{"given":"Anu","family":"Marahatta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bidur","family":"Bhandary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seul-Ki","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Ryong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Jung","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,12]]},"reference":[{"key":"BFsrep04362_CR1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00023210-200115050-00001","volume":"15","author":"SJ Czuczwar","year":"2001","unstructured":"Czuczwar, S. J. & Patsalos, P. N. The new generation of GABA enhancers. Potential in the treatment of epilepsy. CNS Drugs 15, 339\u201350 (2001).","journal-title":"CNS Drugs"},{"key":"BFsrep04362_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004850-200015010-00001","volume":"15","author":"C Lennkh","year":"2000","unstructured":"Lennkh, C. & Simhandl, C. Current aspects of valproate in bipolar disorder. Int Clin Psychopharmacol 15, 1\u201311 (2000).","journal-title":"Int Clin Psychopharmacol"},{"key":"BFsrep04362_CR3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/CAD.0000000000000040","volume":"25","author":"M Slingerland","year":"2014","unstructured":"Slingerland, M., Guchelaar, H. J. & Gelderblom, H. Histone deacetylase inhibitors: an overview of the clinical studies in solid tumors. Anticancer Drugs 25, 140\u20139 (2014).","journal-title":"Anticancer Drugs"},{"key":"BFsrep04362_CR4","doi-asserted-by":"crossref","first-page":"139S","DOI":"10.1592\/phco.20.12.139S.35255","volume":"20","author":"JC Cloyd","year":"2000","unstructured":"Cloyd, J. C. & Remmel, R. P. Antiepileptic drug pharmacokinetics and interactions: impact on treatment of epilepsy. Pharmacotherapy 20, 139S\u2013151S (2000).","journal-title":"Pharmacotherapy"},{"key":"BFsrep04362_CR5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0090-9556(24)15356-1","volume":"28","author":"S Kumar","year":"2000","unstructured":"Kumar, S. et al. Disposition of valproic acid in maternal, fetal and newborn sheep. II: metabolism and renal elimination. Drug Metab Dispos 28, 857\u201364 (2000).","journal-title":"Drug Metab Dispos"},{"key":"BFsrep04362_CR6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/dmd.108.022426","volume":"37","author":"UA Argikar","year":"2009","unstructured":"Argikar, U. A. & Remmel, R. P. Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8 and UGT1A10. Drug Metab Dispos 37, 229\u201336 (2009).","journal-title":"Drug Metab Dispos"},{"key":"BFsrep04362_CR7","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1124\/jpet.104.081968","volume":"313","author":"S Krishnaswamy","year":"2005","unstructured":"Krishnaswamy, S. et al. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: II. Functional impact of the three most common nonsynonymous UGT1A6 polymorphisms (S7A, T181A and R184S). J Pharmacol Exp Ther 313, 1340\u20136 (2005).","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsrep04362_CR8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.clpt.6100324","volume":"83","author":"JY Chung","year":"2008","unstructured":"Chung, J. Y. et al. Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects. Clin Pharmacol Ther 83, 595\u2013600 (2008).","journal-title":"Clin Pharmacol Ther"},{"key":"BFsrep04362_CR9","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0006-2952(03)00076-5","volume":"65","author":"BT Ethell","year":"2003","unstructured":"Ethell, B. T., Anderson, G. D. & Burchell, B. The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases. Biochem Pharmacol 65, 1441\u20139 (2003).","journal-title":"Biochem Pharmacol"},{"key":"BFsrep04362_CR10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-0037-1621430","volume":"28","author":"U Wenzel","year":"2008","unstructured":"Wenzel, U., Fuchs, D. & Daniel, H. Protective effects of soy-isoflavones in cardiovascular disease. Identification of molecular targets. Hamostaseologie 28, 85\u20138 (2008).","journal-title":"Hamostaseologie"},{"key":"BFsrep04362_CR11","first-page":"33","volume":"19","author":"K Taku","year":"2010","unstructured":"Taku, K. et al. Effect of soy isoflavone extract supplements on bone mineral density in menopausal women: meta-analysis of randomized controlled trials. Asia Pac J Clin Nutr 19, 33\u201342 (2010).","journal-title":"Asia Pac J Clin Nutr"},{"key":"BFsrep04362_CR12","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1007\/s10620-006-9251-9","volume":"52","author":"B Ustundag","year":"2007","unstructured":"Ustundag, B. et al. Protective effect of soy isoflavones and activity levels of plasma paraoxonase and arylesterase in the experimental nonalcoholic steatohepatitis model. Dig Dis Sci 52, 2006\u201314 (2007).","journal-title":"Dig Dis Sci"},{"key":"BFsrep04362_CR13","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/aje\/kwm242","volume":"166","author":"WH Xu","year":"2007","unstructured":"Xu, W. H. et al. Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer. Am J Epidemiol 166, 1420\u201330 (2007).","journal-title":"Am J Epidemiol"},{"key":"BFsrep04362_CR14","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/bmj.38093.646215.AE","volume":"328","author":"WH Xu","year":"2004","unstructured":"Xu, W. H. et al. Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study. BMJ 328, 1285 (2004).","journal-title":"BMJ"},{"key":"BFsrep04362_CR15","doi-asserted-by":"crossref","first-page":"146S","DOI":"10.1080\/07315724.2005.10719456","volume":"24","author":"TM Badger","year":"2005","unstructured":"Badger, T. M., Ronis, M. J., Simmen, R. C. & Simmen, F. A. Soy protein isolate and protection against cancer. J Am Coll Nutr 24, 146S\u2013149S (2005).","journal-title":"J Am Coll Nutr"},{"key":"BFsrep04362_CR16","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2174\/18715206113139990320","volume":"13","author":"CC Douglas","year":"2013","unstructured":"Douglas, C. C., Johnson, S. A. & Arjmandi, B. H. Soy and its isoflavones: the truth behind the science in breast cancer. Anticancer Agents Med Chem 13, 1178\u201387 (2013).","journal-title":"Anticancer Agents Med Chem"},{"key":"BFsrep04362_CR17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/000313480206800612","volume":"68","author":"JL Jones","year":"2002","unstructured":"Jones, J. L., Daley, B. J., Enderson, B. L., Zhou, J. R. & Karlstad, M. D. Genistein inhibits tamoxifen effects on cell proliferation and cell cycle arrest in T47D breast cancer cells. Am Surg 68, 575\u20137; discussion 577\u20138 (2002).","journal-title":"Am Surg"},{"key":"BFsrep04362_CR18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0278-6915(97)00171-3","volume":"36","author":"NA Helsby","year":"1998","unstructured":"Helsby, N. A., Chipman, J. K., Gescher, A. & Kerr, D. Inhibition of mouse and human CYP 1A- and 2E1-dependent substrate metabolism by the isoflavonoids genistein and equol. Food Chem Toxicol 36, 375\u201382 (1998).","journal-title":"Food Chem Toxicol"},{"key":"BFsrep04362_CR19","doi-asserted-by":"crossref","first-page":"e699","DOI":"10.1542\/peds.2011-3350","volume":"130","author":"AG Fruzza","year":"2012","unstructured":"Fruzza, A. G., Demeterco-Berggren, C. & Jones, K. L. Unawareness of the effects of soy intake on the management of congenital hypothyroidism. Pediatrics 130, e699\u2013702 (2012).","journal-title":"Pediatrics"},{"key":"BFsrep04362_CR20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1517\/14740338.5.3.433","volume":"5","author":"EA Nutescu","year":"2006","unstructured":"Nutescu, E. A., Shapiro, N. L., Ibrahim, S. & West, P. Warfarin and its interactions with foods, herbs and other dietary supplements. Expert Opin Drug Saf 5, 433\u201351 (2006).","journal-title":"Expert Opin Drug Saf"},{"key":"BFsrep04362_CR21","first-page":"2474","volume":"62","author":"YH Ju","year":"2002","unstructured":"Ju, Y. H., Doerge, D. R., Allred, K. F., Allred, C. D. & Helferich, W. G. Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res 62, 2474\u20137 (2002).","journal-title":"Cancer Res"},{"key":"BFsrep04362_CR22","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/jn\/129.10.1820","volume":"129","author":"LC Appelt","year":"1999","unstructured":"Appelt, L. C. & Reicks, M. M. Soy induces phase II enzymes but does not inhibit dimethylbenz[a]anthracene-induced carcinogenesis in female rats. J Nutr 129, 1820\u20136 (1999).","journal-title":"J Nutr"},{"key":"BFsrep04362_CR23","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1089\/jmf.2009.0084","volume":"12","author":"EB Froyen","year":"2009","unstructured":"Froyen, E. B., Reeves, J. L., Mitchell, A. E. & Steinberg, F. M. Regulation of phase II enzymes by genistein and daidzein in male and female Swiss Webster mice. J Med Food 12, 1227\u201337 (2009).","journal-title":"J Med Food"},{"key":"BFsrep04362_CR24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/03602530701690341","volume":"39","author":"H Mori","year":"2007","unstructured":"Mori, H., Takahashi, K. & Mizutani, T. Interaction between valproic acid and carbapenem antibiotics. Drug Metab Rev 39, 647\u201357 (2007).","journal-title":"Drug Metab Rev"},{"key":"BFsrep04362_CR25","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jhep.2010.01.010","volume":"52","author":"TJ Erichsen","year":"2010","unstructured":"Erichsen, T. J. et al. Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids. J Hepatol 52, 570\u20138 (2010).","journal-title":"J Hepatol"},{"key":"BFsrep04362_CR26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0731-7085(00)00491-X","volume":"25","author":"N Hanioka","year":"2001","unstructured":"Hanioka, N., Jinno, H., Tanaka-Kagawa, T., Nishimura, T. & Ando, M. Determination of UDP-glucuronosyltransferase UGT1A6 activity in human and rat liver microsomes by HPLC with UV detection. J Pharm Biomed Anal 25, 65\u201375 (2001).","journal-title":"J Pharm Biomed Anal"},{"key":"BFsrep04362_CR27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neuropharm.2005.09.007","volume":"50","author":"T Heurtaux","year":"2006","unstructured":"Heurtaux, T. et al. Induction of UGT1A6 isoform by inflammatory conditions in rat astrocytes. Neuropharmacology 50, 317\u201328 (2006).","journal-title":"Neuropharmacology"},{"key":"BFsrep04362_CR28","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1124\/dmd.31.9.1125","volume":"31","author":"MH Court","year":"2003","unstructured":"Court, M. H. et al. Evaluation of 3\u2032-azido-3\u2032-deoxythymidine, morphine and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism. Drug Metab Dispos 31, 1125\u201333 (2003).","journal-title":"Drug Metab Dispos"},{"key":"BFsrep04362_CR29","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00204-011-0690-5","volume":"85","author":"N Hanioka","year":"2011","unstructured":"Hanioka, N., Oka, H., Nagaoka, K., Ikushiro, S. & Narimatsu, S. Effect of UDP-glucuronosyltransferase 2B15 polymorphism on bisphenol A glucuronidation. Arch Toxicol 85, 1373\u201381 (2011).","journal-title":"Arch Toxicol"},{"key":"BFsrep04362_CR30","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.neuropharm.2010.10.021","volume":"60","author":"A Guidotti","year":"2011","unstructured":"Guidotti, A. et al. Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology 60, 1007\u201316 (2011).","journal-title":"Neuropharmacology"},{"key":"BFsrep04362_CR31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1211\/0022357001773986","volume":"52","author":"H Yoshioka","year":"2000","unstructured":"Yoshioka, H. et al. Effects of lithium on the pharmacokinetics of valproate in rats. J Pharm Pharmacol 52, 297\u2013301 (2000).","journal-title":"J Pharm Pharmacol"},{"key":"BFsrep04362_CR32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2165\/00003088-200544050-00005","volume":"44","author":"I Ragueneau-Majlessi","year":"2005","unstructured":"Ragueneau-Majlessi, I. et al. Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy. Clin Pharmacokinet 44, 517\u201323 (2005).","journal-title":"Clin Pharmacokinet"},{"key":"BFsrep04362_CR33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/39.2.295","volume":"39","author":"K Nagai","year":"1997","unstructured":"Nagai, K. et al. Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem\/betamipron. J Antimicrob Chemother 39, 295\u20136 (1997).","journal-title":"J Antimicrob Chemother"},{"key":"BFsrep04362_CR34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/42.4.563","volume":"42","author":"BJ De Turck","year":"1998","unstructured":"De Turck, B. J. et al. Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin. J Antimicrob Chemother 42, 563\u20134 (1998).","journal-title":"J Antimicrob Chemother"},{"key":"BFsrep04362_CR35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/01635589709514587","volume":"28","author":"LC Appelt","year":"1997","unstructured":"Appelt, L. C. & Reicks, M. M. Soy feeding induces phase II enzymes in rat tissues. Nutr Cancer 28, 270\u20135 (1997).","journal-title":"Nutr Cancer"},{"key":"BFsrep04362_CR36","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1124\/dmd.111.039149","volume":"39","author":"SL Navarro","year":"2011","unstructured":"Navarro, S. L. et al. UGT1A6 and UGT2B15 polymorphisms and acetaminophen conjugation in response to a randomized, controlled diet of select fruits and vegetables. Drug Metab Dispos 39, 1650\u20137 (2011).","journal-title":"Drug Metab Dispos"},{"key":"BFsrep04362_CR37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/15287399209531604","volume":"35","author":"MH Siess","year":"1992","unstructured":"Siess, M. H., Le Bon, A. M. & Suschetet, M. Dietary modification of drug-metabolizing enzyme activities: dose-response effect of flavonoids. J Toxicol Environ Health 35, 141\u201352 (1992).","journal-title":"J Toxicol Environ Health"},{"key":"BFsrep04362_CR38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0278-6915(93)90189-6","volume":"31","author":"JC Mirsalis","year":"1993","unstructured":"Mirsalis, J. C., Hamilton, C. M., Schindler, J. E., Green, C. E. & Dabbs, J. E. Effects of soya bean flakes and liquorice root extract on enzyme induction and toxicity in B6C3F1 mice. Food Chem Toxicol 31, 343\u201350 (1993).","journal-title":"Food Chem Toxicol"},{"key":"BFsrep04362_CR39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10585-010-9336-x","volume":"27","author":"MM Martinez-Montemayor","year":"2010","unstructured":"Martinez-Montemayor, M. M. et al. Individual and combined soy isoflavones exert differential effects on metastatic cancer progression. Clin Exp Metastasis 27, 465\u201380 (2010).","journal-title":"Clin Exp Metastasis"},{"key":"BFsrep04362_CR40","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0090-9556(24)15189-6","volume":"28","author":"T Walle","year":"2000","unstructured":"Walle, T., Otake, Y., Galijatovic, A., Ritter, J. K. & Walle, U. K. Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in the human hepatoma cell line hep G2. Drug Metab Dispos 28, 1077\u201382 (2000).","journal-title":"Drug Metab Dispos"},{"key":"BFsrep04362_CR41","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1023\/A:1011019417236","volume":"18","author":"A Galijatovic","year":"2001","unstructured":"Galijatovic, A., Otake, Y., Walle, U. K. & Walle, T. Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in Caco-2 cells--potential role in carcinogen bioinactivation. Pharm Res 18, 374\u20139 (2001).","journal-title":"Pharm Res"},{"key":"BFsrep04362_CR42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0301-0082(82)90010-7","volume":"19","author":"A Chapman","year":"1982","unstructured":"Chapman, A., Keane, P. E., Meldrum, B. S., Simiand, J. & Vernieres, J. C. Mechanism of anticonvulsant action of valproate. Prog Neurobiol 19, 315\u201359 (1982).","journal-title":"Prog Neurobiol"},{"key":"BFsrep04362_CR43","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1528-1157.1984.tb05630.x","volume":"25 Suppl 1","author":"D Johnston","year":"1984","unstructured":"Johnston, D. Valproic acid: update on its mechanisms of action. Epilepsia 25 Suppl 1, S1\u20134 (1984).","journal-title":"Epilepsia"},{"key":"BFsrep04362_CR44","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1111\/j.1528-1157.1984.tb05637.x","volume":"25 Suppl 1","author":"M Morre","year":"1984","unstructured":"Morre, M., Keane, P. E., Vernieres, J. C., Simiand, J. & Roncucci, R. Valproate: recent findings and perspectives. Epilepsia 25 Suppl 1, S5\u20139 (1984).","journal-title":"Epilepsia"},{"key":"BFsrep04362_CR45","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0022-3565(25)32998-8","volume":"220","author":"H Nau","year":"1982","unstructured":"Nau, H. & Loscher, W. Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse. J Pharmacol Exp Ther 220, 654\u20139 (1982).","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsrep04362_CR46","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.biocel.2011.06.010","volume":"43","author":"GH Lee","year":"2011","unstructured":"Lee, G. H. et al. The roles of ER stress and P450 2E1 in CCl(4)-induced steatosis. Int J Biochem Cell Biol 43, 1469\u201382 (2011).","journal-title":"Int J Biochem Cell Biol"},{"key":"BFsrep04362_CR47","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/carcin\/bgg117","volume":"24","author":"EM van der Logt","year":"2003","unstructured":"van der Logt, E. M., Roelofs, H. M., Nagengast, F. M. & Peters, W. H. Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens. Carcinogenesis 24, 1651\u20136 (2003).","journal-title":"Carcinogenesis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep04362.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep04362","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep04362.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T01:36:48Z","timestamp":1746149808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep04362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,12]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep04362"],"URL":"https:\/\/doi.org\/10.1038\/srep04362","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,12]]},"assertion":[{"value":"12 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4362"}}